FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Amerisource Health Services Verapamil Hydrochloride Extended-Release Recall

Verapamil Hydrochloride Extended-Release Tablets, USP, 120 mg, Rx Only, 100 Tablets per…

Amerisource Health Services LLC · Columbus, OH

Risk level
Class II
Reported by FDA
Mar 15, 2023
Recall ID
D-0436-2023
Check your lot numberHow we source this data

Summary

Amerisource Health Services recalled Verapamil Hydrochloride Extended-Release starting Jan 27, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0436-2023 on Mar 15, 2023. Reason: Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values. Status: Terminated.

Why it was recalled

Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values.

Product description

Verapamil Hydrochloride Extended-Release Tablets, USP, 120 mg, Rx Only, 100 Tablets per Carton (10 x 10), Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-493-01; NDC Unit Dose: 60687-493-11.

Lot numbers, UPCs & expiration codes

Lot 1009065, Exp 12/31/2023

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0436-2023
Classification
Class II
Status
Terminated
Recall initiated
Jan 27, 2023
FDA report date
Mar 15, 2023
Quantity
422 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Amerisource Health Services LLC

Original FDA data

Every field from FDA enforcement report D-0436-2023, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Terminated
Country
United States
Event ID
91670
Address
2550 John Glenn Ave Ste A
Code information
Lot 1009065, Exp 12/31/2023
Postal code
43217-1188
Report date
Mar 15, 2023
Product type
Drugs
Recall number
D-0436-2023
Classification
Class II
Recalling firm
Amerisource Health Services LLC
Product quantity
422 cartons
Termination date
May 12, 2024
Reason for recall
Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Verapamil Hydrochloride Extended-Release Tablets, USP, 120 mg, Rx Only, 100 Tablets per Carton (10 x 10), Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-493-01; NDC Unit Dose: 60687-493-11.
Distribution pattern
Nationwide in the USA
Recall initiation date
Jan 27, 2023
Initial firm notification
Letter
Center classification date
Mar 6, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0436-2023, published Mar 15, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls